Delivery Order SPE2DB20D2104-SPE2DB25FMWHS
- Not listed
- The Defense Logistics Agency awarded a $9,100.35 delivery order to AmerisourceBergen Drug Corp for VISCOAT syringes (0.5mL) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that runs through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5mL) under a firm fixed price contract valued at $6,671.75. The award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Viscoat Syringes (0.5 mL), valued at $3,087.53. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $3,109.08 delivery order to AmerisourceBergen Drug Corp for VISCOAT Syringe 0.5ML, with an ultimate completion date of October 23, 2025. This firm fixed-price contract, awarded on October 22, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award utilized no set-aside designation and will be...
- On September 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,640.14 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringe 0.5ML medical devices. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 19, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.75 to AmerisourceBergen Drug Corp for 0.5mL Viscoat syringes, with an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office based in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viscoat syringes (0.5ml) valued at $27,117.66. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will take place at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,172.83 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5mL) under a firm fixed-price contract. The order, awarded on September 22, 2025, with an ultimate completion date of September 23, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $3,213.13 delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on April 28, 2025, with completion scheduled for April 29, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation. Performance will...
- The Defense Logistics Agency awarded a $6,557.19 delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5ml) under a firm fixed price contract with a completion date of September 24, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical and medical supply distribution operations supporting federal...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWHSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,697.60 to AmerisourceBergen Drug Corp for VISCOAT Syringe 0.5ML on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The award represents a small-value transaction within the company's extensive portfolio of federal medical procurement contracts. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies critical medical commodities including medications, vaccines, syringes, and related medical supplies to support military healthcare programs. The company's federal contract awards demonstrate its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/24/25 |